sTREM-1 is a specific biomarker of TREM-1 pathway activation

被引：43

作者：

Jolly, Lucie ^{[1
]}

Carrasco, Kevin ^{[1
]}

Salcedo-Magguilli, Margarita ^{[1
]}

Garaud, Jean-Jacques ^{[1
]}

Lambden, Simon ^{[1
]}

van der Poll, Tom ^{[2
]}

Mebazaa, Alexandre ^{[3
,4
]}

Laterre, Pierre-Francois ^{[5
]}

Gibot, Sebastien ^{[6
,7
]}

Boufenzer, Amir ^{[1
]}

Derive, Marc ^{[1
]}

机构：

[1] Inotrem, Vandoeuvre Les Nancy, France

[2] Univ Amsterdam, Amsterdam Univ Med Ctr, Div Infect Dis, Amsterdam, Netherlands

[3] St Louis Lariboisiere Fernand Widal Univ Hosp, AP HP, Intens Care Unit, Paris, France

[4] Univ Paris, INSERM, MASCOT, Paris, France

[5] Catholic Univ Louvain, Intens Care Unit, Louvain La Neuve, Belgium

[6] CHRU Nancy, Intens Care Unit, Nancy, France

[7] Univ Lorraine, Nancy, France

来源：

CELLULAR & MOLECULAR IMMUNOLOGY | 2021年 / 18卷 / 08期

关键词：

ECTODOMAIN;

D O I：

10.1038/s41423-021-00733-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：2054 / 2056

页数：3

共 7 条

[1] Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes [J].

Bouchon, A ;

Dietrich, J ;

Colonna, M .

JOURNAL OF IMMUNOLOGY, 2000, 164 (10) :4991-4995

[2] Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis [J].

Boufenzer, Amir ;

Carrasco, Kevin ;

Jolly, Lucie ;

Brustolin, Benjamin ;

Di-Pillo, Elisa ;

Derive, Marc ;

Gibot, Sebastien .

CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (02) :452-460

[3] TREM-1 multimerization is essential for its activation on monocytes and neutrophils [J].

Carrasco, Kevin ;

Boufenzer, Amir ;

Jolly, Lucie ;

Le Cordier, Helene ;

Wang, Guanbo ;

Heck, Albert J. R. ;

Cerwenka, Adelheid ;

Vinolo, Emilie ;

Nazabal, Alexis ;

Kriznik, Alexandre ;

Launay, Pierre ;

Gibot, Sebastien ;

Derive, Marc .

CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 16 (05) :460-472

[4] Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial [J].

Francois, Bruno ;

Wittebole, Xavier ;

Ferrer, Ricard ;

Mira, Jean-Paul ;

Dugernier, Thierry ;

Gibot, Sebastien ;

Derive, Marc ;

Olivier, Aurelie ;

Cuvier, Valerie ;

Witte, Stephan ;

Pickkers, Peter ;

Vandenhende, Francois ;

Garaud, Jean-Jacques ;

Sanchez, Miguel ;

Salcedo-Magguilli, Margarita ;

Laterre, Pierre-Francois .

INTENSIVE CARE MEDICINE, 2020, 46 (07) :1425-1437

[5] Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes [J].

Gomez-Pina, Vanesa ;

Soares-Schanoski, Alessandra ;

Rodriguez-Rojas, Alexandro ;

del Fresno, Carlos ;

Garcia, Felipe ;

Vallejo-Cremades, Maria Teresa ;

Fernandez-Ruiz, Irene ;

Arnalich, Francisco ;

Fuentes-Prior, Pablo ;

Lopez-Collazo, Eduardo .

JOURNAL OF IMMUNOLOGY, 2007, 179 (06) :4065-4073

[6] Targeted endothelial gene deletion of triggering receptor expressed on myeloid cells-1 protects mice during septic shock [J].

Jolly, Lucie ;

Carrasco, Kevin ;

Derive, Marc ;

Lemarie, Jeremie ;

Boufenzer, Amir ;

Gibot, Sebastien .

CARDIOVASCULAR RESEARCH, 2018, 114 (06) :907-918

[7] Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors [J].

Weiss, G. ;

Lai, C. ;

Fife, M. E. ;

Grabiec, A. M. ;

Tildy, B. ;

Snelgrove, R. J. ;

Xin, G. ;

Lloyd, C. M. ;

Hussell, T. .

MUCOSAL IMMUNOLOGY, 2017, 10 (04) :1021-1030

← 1 →